Capital Insight Partners, LLC Pacira Bio Sciences, Inc. Transaction History

Capital Insight Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $296,965 - $446,731	-7,776 Reduced 14.15%	47,190 $1.82 Million
Q3 2022 Oct 20, 2022	SELL	$51.24 - $58.89 $47,960 - $55,121	-936 Reduced 1.67%	54,966 $2.92 Million
Q2 2022 Jul 20, 2022	BUY	$51.49 - $81.64 $70,386 - $111,601	1,367 Added 2.51%	55,902 $3.26 Million
Q1 2022 Apr 21, 2022	SELL	$60.03 - $76.49 $12,546 - $15,986	-209 Reduced 0.38%	54,535 $4.16 Million
Q4 2021 Jan 20, 2022	BUY	$47.97 - $62.21 $73,729 - $95,616	1,537 Added 2.89%	54,744 $3.29 Million
Q3 2021 Oct 13, 2021	BUY	$54.64 - $61.3 $1.24 Million - $1.39 Million	22,646 Added 74.1%	53,207 $2.98 Million
Q2 2021 Aug 02, 2021	BUY	$59.18 - $69.99 $504,213 - $596,314	8,520 Added 38.66%	30,561 $1.85 Million
Q1 2021 Apr 20, 2021	BUY	$59.31 - $78.82 $1.31 Million - $1.74 Million	22,041 New	22,041 $1.55 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Insight Partners, LLC with notifications on news.